Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
about
Treatment of Myelofibrosis: Old and New Strategies.Progression of primary myelofibrosis to polycythemia vera: A case report.An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review.Liver function test abnormalities and their clinical relevance in primary myelofibrosis.Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis.β-Arrestin2 mediates progression of murine primary myelofibrosis.Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.Cardiac tamponade in myelofibrosis: A Mayo clinic series of nine consecutive cases.Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.Benefits and pitfalls of Peg-Interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis, a French Intergroup of Myeloproliferative neoplasms (FIM) study.Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.Pharmacotherapy of Myelofibrosis.Momelotinib therapy for myelofibrosis: a 7-year follow-up.Systemic lupus erythematosus and myelofibrosis: A case report and revision of literature.Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
P2860
Q39349869-D24AF700-B5A8-41D5-98A5-7C84FE5A064CQ41049859-59CA55A0-ABFA-4CC6-8319-D27971A076FCQ41189441-F29D9988-3AD6-4A96-9A7B-62FC8730CFADQ41981294-B3AFCBF1-A6FC-4E1C-8C8B-6A39DA7F9444Q45236578-66D8AFE6-CD71-4C3C-B06F-0A2C43F5C027Q47268946-92B3D206-8C40-48A6-9AE0-67CC51215F2FQ47784419-8F2853AC-9B4C-4132-A59B-78793001E2E0Q48283014-7D1109CF-A7EB-4A9C-9670-AE1931B038AEQ48346406-FD75F831-FA16-4ACB-8CE9-721ADD915523Q49191669-A17BB112-4FE2-4674-9F82-8A82FED4032DQ50020976-A1AC928C-AB9E-4B7B-A6BE-AD893061C3DAQ51733623-E311A9AF-9C18-4057-940D-EF133800A2EFQ53119304-65D832C3-C120-48B9-90C1-690C51B9DC0FQ54998956-6F5675BC-8F9B-42FF-90FE-887244D42276Q55120318-59C307BD-2412-4953-AE78-1570AF85A272Q58695596-57B40584-9D8D-4DE8-8D57-80487F7D0A30
P2860
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@en
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@nl
type
label
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@en
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@nl
prefLabel
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@en
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@nl
P2860
P356
P1476
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
@en
P2860
P304
P356
10.1002/AJH.24592
P577
2016-12-01T00:00:00Z